The European Bank for Reconstruction & Development (EBRD) is lending the H&S Holding-owned Dislog Group companies a MAD 380 million loan to help Morocco’s pharmaceutical private sector, announced a press release.
Out of the loan, MAD 270 million will fund the purchase of Steripharma, a regional pharmaceutical business that produces specialty generic medications in the treatment of life-threatening disorders.
The remaining MAD 100 million in the loan will be used to develop a new industrial building with green certification and a logistics platform, as well as to install photovoltaic (PV) panels to provide electricity for the facility and lower CO2 emissions.
Morocco first benefited from bank funding in 2012. Through 95 projects, the EBRD has so far contributed €4.2 billion to the nation.